Dosing and Administration Standard Dose : 50 mg once daily or as directed by a licensed healthcare provider Route : Oral capsule Timing : Preferably taken in the morning with or without food Duration : Often used in 48 week cycles depending on clinical goals Because 5-Amino-1MQ modulates key metabolic pathways, it is strongly recommended that patients be monitored by a practitioner, especially when used alongside other metabolic or NAD therapies
Potential risks include: Infection risk if injections are administered in non-clinical settings without appropriate sterile technique Allergic reactions to any component of the formulation Liver toxicity theoretical concern with excessive methionine or choline Drug interactions particularly if combined with other supplements or medications Unknown long-term effects due to absence of longitudinal safety data The MHRA advises caution with unlicensed injectable products, as quality, purity, and sterility cannot be guaranteed
The compound moved through Phase I trials, which primarily assess safety in humans, and appeared to have a very favorable safety profile
To maintain purity and stability: Once the vial has been punctured, the presence of benzyl alcohol helps preserve the solution
In addition, it is also hypothesized that altered gastric physiology may indirectly reduce intrinsic factor levels
